References
1. Peerless SA, Noiman AH. Etiology of otitis media with effusion: antihistamines–decongestants. Laryngoscope 1980; 90:1852-1864.
2. Alberty J, Stoll W. The effect of antiallergic intranasal formulations on ciliary beat frequency of human nasal epithelium in vitro. Allergy 1998; 53:986-989.
3. Joki S, Toskala E, Saano V, Nuutinen J. Correlation between ciliary beat frequency and the structure of ciliated epithelia in pathologic human nasal mucosa. Laryngoscope 1998; 108:426-430.
4. Li D, Shirakami G, Zhan X, Johns RA. Regulation of ciliary beat frequency by the nitric oxide-cyclic guanosine monophosphate signaling pathway in rat airway epithelial cells. Am J Respir Cell Mol Biol 2000; 23:175-181.
5. Seresirikachorn K, Khattiyawittayakun L, Chitsuthipakorn W, Snidvongs K. Antihistamines for treating rhinosinusitis: systematic review and meta-analysis of randomised controlled studies. J Laryngol Otol 2018; 132:105-110.
6. Braverman I, Wright ED, Wang CG, Eidelman D, Frenkiel S. Human nasal ciliary-beat frequency in normal and chronic sinusitis subjects. J Otolaryngol 1998; 27:145-152.
7. Wang DY, Wardani RS, Singh K et al. A survey on the management of acute rhinosinusitis among Asian physicians. Rhinology 2011; 49:264-271.
8. Dykewicz MS, Hamilos DL. Rhinitis and sinusitis. J Allergy Clin Immunol 2010; 125:S103-115.
9. Kirtsreesakul V, Blair C, Yu X, Thompson K, Naclerio RM. Desloratadine partially inhibits the augmented bacterial responses in the sinuses of allergic and infected mice. Clin Exp Allergy 2004; 34:1649-1654.
10. Austin PC. A critical appraisal of propensity-score matching in the medical literature between 1996 and 2003. Stat Med 2008; 27:2037-2049.
11. Dinse GE, Lagakos SW. Nonparametric estimation of lifetime and disease onset distributions from incomplete observations. Biometrics 1982; 38:921-932.
12. Bradburn MJ, Clark TG, Love SB, Altman DG. Survival analysis part II: multivariate data analysis–an introduction to concepts and methods. Br J Cancer 2003; 89:431-436.
13. Chen CF, Wu KG, Hsu MC, Tang RB. Prevalence and relationship between allergic diseases and infectious diseases. J Microbiol Immunol Infect 2001; 34:57-62.
14. Holzmann D, Willi U, Nadal D. Allergic rhinitis as a risk factor for orbital complication of acute rhinosinusitis in children. Am J Rhinol 2001; 15:387-390.
15. Novak I, Falus A. Molecular biology and role of histamine in physiological and pathological reactions. A review. Acta Biol Hung 1997; 48:385-394.
16. Lagier B, Lebel B, Bousquet J, Pene J. Different modulation by histamine of IL-4 and interferon-gamma (IFN-gamma) release according to the phenotype of human Th0, Th1 and Th2 clones. Clin Exp Immunol 1997; 108:545-551.
17. Jeannin P, Delneste Y, Gosset P et al. Histamine induces interleukin-8 secretion by endothelial cells. Blood 1994; 84:2229-2233.
18. Miki I, Kusano A, Ohta S et al. Histamine enhanced the TNF-alpha-induced expression of E-selectin and ICAM-1 on vascular endothelial cells. Cell Immunol 1996; 171:285-288.
19. Bousquet J, Van Cauwenberge P, Khaltaev N, ARIA Workshop G, World Health Organization. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001; 108:S147-334.
20. Antunes MB, Cohen NA. Mucociliary clearance – a critical upper airway host defense mechanism and methods of assessment. Curr Opin Allergy Clin Immunol 2007; 7:5-10.
21. Eliezer N, Sade J, Silberberg A, Nevo AC. The role of mucus in transport by cilia. Am Rev Respir Dis 1970; 102:48-52.
22. Sleigh MA, Blake JR, Liron N. The propulsion of mucus by cilia. Am Rev Respir Dis 1988; 137:726-741.
23. Houtmeyers E, Gosselink R, Gayan-Ramirez G, Decramer M. Regulation of mucociliary clearance in health and disease. Eur Respir J 1999; 13:1177-1188.
Figure legends
Figure 1. Survival curves of Patients in AH and non-AH group (AH; antihistamine, non-AH; non-antihistamine)
Figure 2. In the subgroup analysis of the AH group, there was no significant difference between the four subgroup. (“1 week” if the consecutive duration of antihistamine usage is less than 1 week, “2 week” if the duration is less than 2 week, “1 month” if the duration is less than 4 week, and “over 1 month” if the duration is equal or more than 4 week) (p=0.70)
Table 1. Characteristics of the study population